Nektar Therapeutics reported $139.97M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Agios Pharmaceuticals AGIO:US $ 57.9M 2.75M
ALKERMES ALKS:US $ 452.98M 69.54M
Amgen AMGN:US $ 14842M 257M
Astrazeneca AZN:US $ 23649M 1427M
Baxter International BAX:US $ 3441M 97M
Biogen BIIB:US $ 4211.6M 864.4M
Bluebird Bio BLUE:US $ 266.56M 18.79M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Cara Therapeutics CARA:US $ 15.53M 358K
Eisai 4523:JP Y 280829M 2895M
Eli Lilly And LLY:US $ 13682M 1411.2M
Esperion Therapeutics ESPR:US $ 78.48M 4.16M
Exelixis EXEL:US $ 269.51M 14.18M
Gilead Sciences GILD:US $ 10245M 31M
GlaxoSmithKline GSK:LN 22417M 1030M
Halozyme Therapeutics HALO:US $ 113.15M 1.1M
Immunogen IMGN:US $ 111.78M 8.53M
IONIS PHARMACEUT IONS:US $ 218M 75.82M
Ironwood Pharmaceuticals IRWD:US $ 145.69M 11.32M
Karyopharm Therapeutics KPTI:US $ 68.87M 10.74M
Macrogenics MGNX:US $ 68.86M 1.06M
Mirati Therapeutics MRTX:US $ 122.08M 58.79M
Nektar Therapeutics NKTR:US $ 139.97M 8.95M
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Novartis NOVN:VX SF 29880M 247M
Sarepta Therapeutics SRPT:US $ 373.44M 51.58M
Seattle Genetics SGEN:US $ 698.43M 264.6M
Takeda 4502:JP Y 1918750M 273984M
Teva Pharmaceutical TEVA:IT 11.82B 866M
Xencor XNCR:US $ 44.32M 1.64M
YTE INCY:US $ 742.71M 82.39M